Data sources
ED visit data are collected by the Canadian Institute for Health Information (CIHI) on a fiscal year basis. For ED visits, the main diagnostic code is the “main problem” (MP) that is deemed to be the clinically significant reason for the visit. ED visit data provide only a crude measure of the burden of opioid use. Data are influenced by factors that are unrelated to health status such as availability and accessibility of care, administrative policies and hospital procedures. This may influence comparisons between areas and over time.
For all indicators, data were analyzed by the residence of the patient, not where the ED visit occurred. Ontario residents treated outside of the province were excluded. Data were reported by calendar year, based on year of the ED visit. This report includes ED visit indicators with relevance to public health programming.
Opioid-related ED visits were selected using ICD-10-CA codes T40 (.0 -.4, .6) (i.e., poisoning) and F11 (.0-.9) (i.e., mental and behavioural disorders due to acute intoxication, harmful use, dependence, etc. due to the use of opioids) whether it was the MP or a comorbidity. As such, the counts and rates included in this report are higher than the information presented by Public Health Ontario – Interactive Opioid Tool. Visits where the health care provider documented uncertainty in the diagnosis (diagnosis prefix Q) and visits which resulted in a transfer to another ambulatory care facility were included in the counts. ED visits for mental and behavioural disorders due to multiple drug use (F19) were excluded. Multiple codes can exist for each ED visit. As such, a unique visit number, NACRS key, was used to count the number of visits where at least one of the above codes was captured as the main problem or comorbidity.
In Figure 3, only MP codes were included in the denominator. Diagnosis categories were defined using the following codes: illegal T40 (.0 and .1); prescription T40 (.2-.4, .6); and mental and behavioural disorders (MBD) F11 (.0-.9). Opioid-related ED visits within the prescription category can occur when prescription drugs are obtained from illegitimate sources or from a risky pattern of use (excluding under use) such as deviating from acceptable practice or using for purposes that are not therapeutic.
Definitions
Figures and tables are provided for the following indicators:
- Age-standardized opioid-related ED visit rates by sex
- Age-specific opioid-related ED visits rates in individuals aged 15 to 19 years , 20 to 34 years, 35 to 64 years, 65 years and older
Age-standardized ED visit rate
An age-standardized ED visit rate is the number of ED visits per 100,000 that would occur if the population had the same age distribution as the 2011 Canadian population. This rate provides a single summary number that allows populations with different age compositions to be compared.
Age-specific ED visit rate
This rate is the total number of ED visits in a specified age group per 100,000 population in that age group. The numerator and denominator refer to the same age group.